Dec 23 (Reuters) - South Korean satellite launch company Innospace on Monday launched the first commercial rocket from Brazil's Alcantara Space Center, a milestone for the firm and Brazilian aerospace

Innospace's rocket crashes in first commercial launch in Brazil; shares tumble

A long-awaited change in drug policy by President Donald Trump could bring scientists one step closer to understanding the harms and benefits of marijuana.

Cannabis reclassification could 'open the floodgates' for research, scientists say

We just got a great up-close look at a SpaceX Starlink satellite that recently suffered an anomaly in orbit, thanks to Vantor's WorldView-3 spacecraft.

Doomed SpaceX Starlink satellite photographed from orbit

Food and Drug Administration's approval of an oral version of Novo Nordisk's weight-loss drug Wegovy could potentially expand access to millions of patients and give the Danish company a much-needed fillip in the red-hot market. The first GLP-1 pill specifically for ​obesity, also branded as Wegovy, is a 25-mg oral formulation of semaglutide, the active ingredient in the blockbuster injectable version.

Explainer-What Novo Nordisk's weight-loss pill approval means for company, patients

Dec 23 () - The weight-loss drug market is surging, with biotech firms racing to win share in a sector dominated by Novo Nordisk and Eli Lilly. Analysts forecast the industry will generate about $150 billion in annual sales in the next decade.

最近の投稿